Skip to content

Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids

A Randomized Trial Comparing Laparoscopic Bilateral Occlusion of Uterine Vessels to Uterine Fibroid Embolization for the Treatment of Symptomatic Uterine Fibroids

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00277680
Enrollment
60
Registered
2006-01-16
Start date
2000-12-31
Completion date
2010-04-30
Last updated
2011-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroids

Keywords

uterine fibroids, leiomyoma, laparoscopy, menorrhagia

Brief summary

Women with symptomatic uterine fibroids are treated either by Uterine Fibroid Embolization (UFE) or laparoscopic occlusion. The study hypothesis is that laparoscopic occlusion of uterine vessels and UFE have equal effect on bleeding symptoms. Menstrual bleeding reduction six months after treatment is the main endpoint. Secondary endpoints include participants assessment of symptom relief, and volume reduction of fibroids measured by MRI. We will also investigate possible differences in postoperative course, symptom reduction, complication, and recurrence. Patients are controlled with regular intervals up to five years after treatment.

Detailed description

Uterine fibroid embolization (UFE)has become an alternative to hysterectomy for women with symptoms of uterine fibroids.Follow up studies of this new method have reported relief of menstrual bleeding by 85-90 % of the patients six to twelve months after treatment.Other studies have suggested laparoscopic bilateral occlusion of uterine arteries as an equal effective alternative, but to our knowledge there is no randomized studies published. Patients recruitment : Women with symptoms of uterine fibroids referred to the clinic,who express a desire to avoid hysterectomy. Study hypothesis: Laparoscopic occlusion of uterine vessels and UFE have equal effect on bleeding symptoms. Gynecological examination, ultrasonography and magnetic resonance imaging (MRI) are performed preoperatively and after 1,3 and 6 months. Clinical follow up is planned after 1,3,6,12,24,36 and 60 months.A validated bleeding chard, Pictorial Blood Assessment Chart(PBAC)is filled in by the participants during the last menstruation period before treatment and before each control. A standardized questionnaire to assess the bleeding amount,pressure symptoms, pain, adverse events, other complains and patients satisfaction is also used.

Interventions

PROCEDURELaparoscopic bilateral occlusion of uterine artery
PROCEDURERadiological embolization (UFE)

Sponsors

Ullevaal University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Menorrhagia and/or bulk symptoms associated with uterine fibroids

Exclusion criteria

* Malignancy * Current or planned pregnancy * Small submucous fibroids suitable for hysteroscopic resection * Postmenopausal women * Suspected or known adenomyosis * Uterus size exceeding the umbilical level * Contraindications against laparoscopic surgery

Design outcomes

Primary

MeasureTime frame
Reduction of menstrual bleeding six months after treatment measured by PBAC

Secondary

MeasureTime frame
postoperative pain
recovering time
complications
Patient assessment of symptom reduction including menorrhagia and bulk symptoms
recurrence
secondary interventions
Reduction in fibroids and uterus size measured by ultrasonography and MRI
failures

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026